BioStem Technologies, Inc.

NASDAQ:BSEM

Biotechnology

Healthcare
$3.07 -6.54%

-$0.21 today

Market cap
$52.14M
Beta
0.26
P/E (TTM)
-1.8
EPS (TTM)
-$1.63
52W Low $2.25High $8.40

Volume 0.09M

Average 0.07M

BSEM Net Income

Bottom-line profit, the starting point for calculating cash from operations.

BioStem Technologies, Inc.NASDAQ: BSEM

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income growth accelerates

Q2 FY2026 net income of $8.97M (cash outflow) rose 1489.7% year over year, ahead of the -207.7% change in trailing-twelve-month net income. Sequentially, it rose 1.7% from the prior quarter. Over 3 fiscal years it compounded at -2.6% a year.

Context

  • Net income amounted to 13.9% of revenue in FY2025, up 3.3 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 1 analysts of -$31.78M (+383.0%) for the fiscal year ending Dec 2026, a step up from the -120.6% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-$8.97M+1.7% QoQ
Last fiscal yearDec 2025
-$6.58M-120.6% YoY
LTMJun 2026
-$28.29M-207.7% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1489.7%-1079.0%-2568.7 pp
1 year-120.6%+383.0%+503.6 pp
3-year CAGR-2.6%-38.8%-36.3 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(6.58M) USD
Year-over-year change
-120.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How BSEM compares with its peers on the latest reported figures

No competitor Net Income figures are available to compare.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(1.41M)(7.11M)(8.48M)31.88M(6.58M)
Depreciation & Amortization283.79K243.42K395.32K293.22K381.02K
Deferred Income Tax(689.36K)0003.99M
Stock-Based Compensation403.02K4.9M6.67M00
Change in Working Capital515.9K7.59K(3.54M)(12.01M)(3.98M)
Accounts Receivables(288.25K)262.93K(11.33M)(93.78M)4.43M
Inventory209.35K(135.18K)(263.45K)(1.17M)(1.05M)
Accounts Payables(19.49K)(77.14K)821.57K4.42M(1.5M)
Other Working Capital614.3K(43.03K)8.06M78.52M(5.86M)
Other Non-Cash Items788.99K322.58K1.46M4.31M16.12M
Operating Cash Flow(109.44K)(1.64M)(3.5M)24.48M9.94M
Capital Expenditures(42.85K)(469.48K)(105.33K)(426.57K)(3.35M)
Acquisitions (Net)35K0(105K)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities000(1.25M)1.25M
Investing Cash Flow(7.85K)(469.48K)(210.33K)(1.68M)(2.1M)
Debt Repayment232.42K547.71K797.06K(849.4K)(1.17M)
Common Stock Issued125K50K2.38M642.62K48.33K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(391.79K)0000
Financing Cash Flow357.42K597.71K3.18M(206.78K)(1.12M)
Effect of Forex Changes01.97M000
Net Change in Cash240.13K431.8K(532.73K)22.59M6.72M
Free Cash Flow(152.29K)(2.11M)(3.6M)24.05M6.59M

BioStem Technologies, Inc.

NASDAQ:BSEM

Intrinsic Alpha fair value

Locked

Current Price

$3.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.